Tenapanor Improves Abdominal Symptoms in Patients With IBS-C

MedPage Today·May 31

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Tenapanor, also known as Ibsrela, has been reported to improve abdominal symptoms in patients with irritable bowel syndrome with constipation (IBS-C). The timing of symptom relief with tenapanor may vary. The treatment is being discussed in the context of guidelines and reviews of pharmacotherapy options for IBS-C.

Full coverage

Tenapanor for Irritable Bowel Syndrome With Constipation (IBS-C): A Systematic Review of Randomized Trials Assessing Food and Drug Administration (FDA) Composite Response, Durability, and Risk-of-Bias (RoB-2)

Cureus·Sep 27

AGA Guidelines Guidelines IBS Irritable Bowel Syndrome American Gastroenterological Association

Gastroenterology & Endoscopy News·Jan 4

Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review

Cureus·Nov 22

‘Do not give up too early’: Early nonresponders with IBS-C improve on Ibsrela at 12 weeks

Healio·Oct 23

Irritable bowel syndrome in focus

Medical Independent·Aug 6

View original report at MedPage Today ↗

Fetching the latest headlines…